PNPLA3 Variants Specifically Confer Increased Risk for Histologic Nonalcoholic Fatty Liver Disease But Not Metabolic Disease†,‡

Speliotes, Elizabeth K., Butler, Johannah L., Palmer, Cameron D., Voight, Benjamin F., Hirschhorn, Joel N.·2010·Hepatology

DOI 10.1002/hep.23768

Cited by (362)

Items 101–200 of 362

Association Between Liver-Specific Gene Polymorphisms and Their Expression Levels With Nonalcoholic Fatty Liver Disease
Leon Anton Adams, Scott W. White, Julie A. Marsh, Stephen James Lye, Kristin L. Connor, Richard Maganga, Oyekoya Taiwo Ayonrinde, John Kevin Olynyk, Trevor Anthony Mori, Lawrence Joseph Beilin et al. · 2012 · Hepatology
Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B
Mauro Viganò, Luca V. C. Valenti, Pietro Lampertico, F. Facchetti, Benedetta Maria Motta, Roberta D’Ambrosio, Solange Romagnoli, Paola Dongiovanni, Benedetta Donati, Silvia Rossana Fargion et al. · 2013 · Hepatology
Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels: a retrospective cohort research
Zekai Chen, Hailun Qin, Shaobin Qiu, Guanzhi Chen, Youren Chen · 2019 · Lipids in Health and Disease
Characteristics of non‐obese non‐alcoholic fatty liver disease: Effect of genetic and environmental factors
Yasushi Honda, Masato Yoneda, Takaomi Kessoku, Yuji Ogawa, Wataru Tomeno, Kento Imajo, Hironori Mawatari, Koji Fujita, Hideyuki Hyogo, Takato Ueno et al. · 2016 · Hepatology Research
Modeling PNPLA3‐Associated NAFLD Using Human‐Induced Pluripotent Stem Cells
Samantha Grace Tilson, Carola Maria Morell, An‐Sofie Lenaerts, Seung Bum Park, Zongyi Hu, Benjamin Jenkins, Albert Koulman, T. Jake Liang, Ludovic Vallier · 2021 · Hepatology
The intersection of nonalcoholic fatty liver disease and obesity
Jennifer Woo Baidal, Joel E. Lavine · 2016 · Science Translational Medicine
Gastrointestinal complications of obesity: Non-alcoholic fatty liver disease (NAFLD) and its sequelae
Thomas Karlas, Johannes Wiegand, Thomas Berg · 2013 · Best Practice & Research Clinical Endocrinology & Metabolism
Gut microbiota and non-alcoholic fatty liver disease
Paraskevas Gkolfakis, George Dimitriadis, Κonstantinos Τriantafyllou · 2015 · Hepatobiliary & pancreatic diseases international
Dynamic human liver proteome atlas reveals functional insights into disease pathways
Lili Niu, Philipp Emanuel Geyer, Rajat Gupta, Alberto Santos, Florian Meier, Sophia Doll, Nicolai J. Wewer Albrechtsen, Sabine Klein, Cristina Ortiz, Frank Erhard Uschner et al. · 2022 · Molecular Systems Biology
Identification of a Metabolic, Transcriptomic, and Molecular Signature of Patatin‐Like Phospholipase Domain Containing 3–Mediated Acceleration of Steatohepatitis
Bubu A. Banini, Divya P. Kumar, Sophie C. Cazanave, Mulugeta Seneshaw, Faridoddin Mirshahi, Prasanna K. Santhekadur, Liangsu Wang, Hong-Ping Guan, Abdul M. Oseini, Cristina Alonso et al. · 2020 · Hepatology
Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD
Eduardo Vilar‐Gómez, Carlos Jose Pirola, Silvia C. Sookoian, Laura Wilson, Patricia H. Belt, Tiebing Liang, Wanqing Liu, Naga Chalasani · 2020 · The American Journal of Gastroenterology
Polychlorinated biphenyl exposures differentially regulate hepatic metabolism and pancreatic function: Implications for nonalcoholic steatohepatitis and diabetes
Hongxue Shi, Jian Jan, Josiah Hardesty, Keith Cameron Falkner, Russell A. Prough, Appakalai N. Balamurugan, Sri Prakash Mokshagundam, Suresh T. Chari, Matthew C. Cave · 2018 · Toxicology and Applied Pharmacology
The rs738409 (I148M) variant of the PNPLA3 gene and cirrhosis: a meta-analysis
Jianhua Shen, Yiling Li, Dan Li, Ningning Wang, Lei Jing, Yu‐Hong Huang · 2014 · Journal of Lipid Research
Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes
Aki Juhani Käräjämäki, Risto Bloigu, Heikki Kauma, Y. Antero Kesäniemi, Olli‐Pekka Koivurova, Juha S. Perkiömäki, Heikki V. Huikuri, Olavi H. Ukkola · 2016 · Metabolism
Genetic Polymorphisms of PNPLA3 and SAMM50 Are Associated with Nonalcoholic Fatty Liver Disease in a Korean Population
Goh Eun Chung, Young Lee, Jeong Yoon Yim, Eun Kyung Choe, Min‐Sun Kwak, Jong In Yang, Boram Park, Jong-Eun Lee, Jeong A. Kim, Joo Sung Kim · 2017 · Gut and Liver
Established and emerging factors affecting the progression of nonalcoholic fatty liver disease
Stergios Kechagias, Patrik Nasr, Julia Blomdahl, Mattias Ekstedt · 2020 · Metabolism
PNPLA3 I148M variant and hepatocellular carcinoma: A common genetic variant for a rare disease
Luca V. C. Valenti, Paola Dongiovanni, Stefano Ginanni Corradini, Maria Antonella Burza, Stefano Romeo · 2013 · Digestive and Liver Disease
Genetic modifiers of non-alcoholic fatty liver disease progression
Quentin Mark Anstee, Ann K. Daly, Christopher Paul Day · 2011 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Genome-wide analysis of hepatic lipid content in extreme obesity
Johanna Kay DiStefano, Christopher B. Kingsley, G. Craig Wood, Xin Chu, George A. Argyropoulos, Christopher D. Still, Stefania Cotta Doné, Christophe Legendre, Waibhav Tembe, Glenn S. Gerhard · 2014 · Acta Diabetologica
Glucokinase links Krüppel-like factor 6 to the regulation of hepatic insulin sensitivity in nonalcoholic fatty liver disease
Lars P. Bechmann, Amalia Gastaldelli, Diana Vetter, Gillian Patman, Laura A. Pascoe, Rebekka A. Hannivoort, Ursula E. Lee, Maria Isabel Fiel, Úrsula Muñoz, Demetrio Ciociaro et al. · 2011 · Hepatology
PNPLA3 polymorphisms (rs738409) and non‐alcoholic fatty liver disease risk and related phenotypes: a meta‐analysis
Long Zhang, Wei You, Hanze Zhang, Rui Peng, Qin Zhu, Aihua Yao, Xiangcheng Li, Yebin Zhou, Xuehao Wang, Liyong Pu et al. · 2015 · Journal of Gastroenterology and Hepatology
A gene variant of PNPLA3, but not of APOC3, is associated with histological parameters of NAFLD in an obese population
An Verrijken, Sigri Beckers, Sven Francque, Hannele Hilden, Sandrine Caron, Doreen Zegers, Martin Ruppert, Guy Hubens, Eric Van Marck, Peter P. Michielsen et al. · 2013 · Obesity
PNPLA3, the triacylglycerol synthesis/hydrolysis/storage dilemma, and nonalcoholic fatty liver disease
Silvia C. Sookoian · 2012 · World Journal of Gastroenterology
17‐Beta Hydroxysteroid Dehydrogenase 13 Deficiency Does Not Protect Mice From Obesogenic Diet Injury
Yanling Ma, Philip M. Brown, Dennis D. Lin, Jing Ma, Dechun Feng, Olga V. Belyaeva, Maren Catherina Podszun, Jason Roszik, Joselyn Natasha Allen, Regina Umarova et al. · 2020 · Hepatology
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease
Ann K. Daly, Stefano Ballestri, Lucia Carulli, Paola Loria, Christopher Paul Day · 2011 · Expert Review of Gastroenterology & Hepatology
Usefulness of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging in assessment of non-alcoholic fatty liver disease
Ying Ding, Shengxiang Rao, Tao Meng, Caizhong Chen, Ren-Chen Li, Mengsu Zeng · 2014 · European Radiology
Role of the PNPLA3 I148M Polymorphism in Nonalcoholic Fatty Liver Disease and Fibrosis in Korea
Sang Soo Lee, Young-Sang Byoun, Sook‐Hyang Jeong, Byung-Hyun Woo, Eun Sun Jang, Jin‐Wook Kim, Hyun Young Kim · 2014 · Digestive Diseases and Sciences
A genetic risk score is associated with hepatic triglyceride content and non-alcoholic steatohepatitis in Mexicans with morbid obesity
Paola León‐Mimila, Joel Vega‐Badillo, Roxana Gutiérrez‐Vidal, Hugo Villamil‐Ramírez, María Teresa Villarreal-Molina, Elena Larrieta‐Carrasco, Blanca Estela López-Contreras, Luis R. Macías Kauffer, Diana Gabriela Maldonado Pintado, Nahúm Méndez‐Sánchez et al. · 2015 · Experimental and Molecular Pathology
A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains
G. Craig Wood, Xin Chu, George A. Argyropoulos, Peter N. Benotti, David D.K. Rolston, Tooraj Mirshahi, Anthony T. Petrick, John Gabrielson, David J. Carey, Johanna Kay DiStefano et al. · 2017 · Scientific Reports
Hepatocyte X-box binding protein 1 deficiency increases liver injury in mice fed a high-fat/sugar diet.
Xiao-Ying Liu, Anne S. Henkel, Brian E. LeCuyer, M. Schipma, K. Anderson, R. Green · 2015 · American Journal of Physiology - Gastrointestinal and Liver Physiology
PNPLA3 I148M variant in nonalcoholic fatty liver disease: Demographic and ethnic characteristics and the role of the variant in nonalcoholic fatty liver fibrosis
Lizhen Chen, Yongning Xin, Ning Geng, Man Jiang, Dingding Zhang, Shiying Xuan · 2015 · World Journal of Gastroenterology
Genetic Variants in PNPLA3 and Risk of Non-Alcoholic Fatty Liver Disease in a Han Chinese Population
Xian‐E Peng, Yunli Wu, Shaowei Lin, Qingqing Lu, Zhijian Hu, Lin Xu · 2012 · PLoS ONE
Insights from Genome-Wide Association Analyses of Nonalcoholic Fatty Liver Disease
Bratati Kahali, Brian D. Halligan, Elizabeth K. Speliotes · 2015 · Seminars in Liver Disease
The genetic backgrounds in nonalcoholic fatty liver disease
Yuya Seko, Kanji Yamaguchi, Yoshito Itoh · 2018 · Clinical Journal of Gastroenterology
Genetic variants that associate with cirrhosis have pleiotropic effects on human traits
Vincent Lingzhi Chen, Yanhua Chen, Xiaomeng Du, Samuel K. Handelman, Elizabeth K. Speliotes · 2019 · Liver International
Patatin-like phospholipase domain containing-3gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis
Luca V. C. Valenti · 2012 · World Journal of Gastroenterology
Systematic review of performance of non-invasive biomarkers in the evaluation of non-alcoholic fatty liver disease
Michael H. Miller, Michael A. J. Ferguson, John Francis Dillon · 2011 · Liver International
PNPLA3 as a Genetic Determinant of Risk for and Severity of Non-alcoholic Fatty Liver Disease Spectrum
Habeeb M. Salameh, Muhannad Al Hanayneh, Maen M. Masadeh, Mohammed Naseemuddin, Tasnia Matin, Angelika Erwin, Ashwani Kumar Singal · 2016 · Journal of Clinical and Translational Hepatology
Abdominal fat interacts with PNPLA 3 I148M, but not with the APOC 3 variant in the pathogenesis of liver steatosis in chronic hepatitis C
Rosa Zampino, Nicola Coppola, Grazia Cirillo, Adriana Boemio, Mariantonietta Pisaturo, Aldo Marrone, Margherita Macera, Evangelista Sagnelli, Laura Perrone, Luigi Elio Adinolfi et al. · 2013 · Journal of Viral Hepatitis
Investigation of PNPLA3 and IL28B Genotypes on Diabetes and Obesity After Liver Transplantation: Insight Into Mechanisms of Disease
Kymberly D. S. Watt, Ross Dierkhising, Chun Li Fan, Julie K. Heimbach, Hans L. Tillman, David B. Goldstein, A. Thompson, A. Krishnan, Michael Charlton · 2013 · American Journal of Transplantation
The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases
Nicholas Chew, Bryan Chong, Cheng Han Ng, Gwyneth Kong, Yip Han Chin, Wang Xiao, Chang Jie Mick Lee, Yock Young Dan, Mark Dhinesh Muthiah, Roger Foo · 2022 · Frontiers in Genetics
Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection—Liver: The “Musketeer” in the Spotlight
Stefano Ballestri, Fabio Nascimbeni, Dante Romagnoli, Enrica Baldelli, Giovanni Targher, Amedeo Lonardo · 2016 · International Journal of Molecular Sciences
Update on genetics and epigenetics in metabolic associated fatty liver disease
Xiaopeng Zhu, Mingfeng Xia, Xin Gao · 2022 · Therapeutic Advances in Endocrinology and Metabolism
PNPLA3 in end‐stage liver disease: Alcohol consumption, hepatocellular carcinoma development, and transplantation‐free survival
Kilian Friedrich, Andreas Wannhoff, Stefan Kattner, Maik Brune, Johannes R. Hov, Karl Heinz Weiss, Christoph Antoni, Matthias Dollinger, Christoph Neumann‐Haefelin, Thomas Theodor Werner Seufferlein et al. · 2014 · Journal of Gastroenterology and Hepatology
Nonalcoholic fatty liver disease and the heart in children and adolescents.
Lucia Pacifico, Claudio Chiesa, Caterina Anania, Antonio De Merulis, John Frederick Osborn, Sara Romaggioli, Eugenio Gaudio · 2014 · PubMed Central
Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment
Vincent Lingzhi Chen, Annapurna Kuppa, Antonino Oliveri, Yanhua Chen, Prabhu Ponnandy, Puja B. Patel, Nicholette D. Palmer, Elizabeth K. Speliotes · 2025 · Journal of Clinical Investigation
Genetic variants in candidate genes influencing NAFLD progression
Michelino Di Rosa, Lucia Malaguarnera · 2011 · Journal of Molecular Medicine
Withdrawal: Hepatic manifestations of metabolic syndrome
Roberto Medina‐Santillán, Jorge A. López‐Velázquez, Norberto Carlos Chávez-Tapia, Gonzalo Torres‐Villalobos, Misael Uribe, Nahúm Méndez‐Sánchez · 2013 · Diabetes/Metabolism Research and Reviews · Retracted
Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection
Chung‐Feng Huang, Chia‐Yen Dai, Ming‐Lun Yeh, Ching‐I Huang, Chi‐Ming Tai, Meng‐Hsuan Hsieh, Po‐Cheng Liang, Yi‐Hung Lin, Ming‐Yen Hsieh, Hualing Yang et al. · 2014 · Journal of Hepatology
Cholesteryl ester transfer protein gene polymorphisms increase the risk of fatty liver in females independent of adiposity
Leon Anton Adams, Julie A. Marsh, Oyekoya Taiwo Ayonrinde, John Kevin Olynyk, Wei Ang, Lawrence Joseph Beilin, Trevor Anthony Mori, Lyle John Palmer, Wendy Hazel Oddy, Stephen James Lye et al. · 2012 · Journal of Gastroenterology and Hepatology
Sex difference in liver diseases: How preclinical models help to dissect the sex-related mechanisms sustaining NAFLD and hepatocellular carcinoma
Alfredo Smiriglia, Nicla Lorito, Marina Serra, Andrea Perra, Andrea Morandi, Marta Anna Kowalik · 2023 · iScience
Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin
Mariana Lazo, Usama Bilal, Rafael Pérez‐Escamilla · 2015 · Current Diabetes Reports
I148M variant of PNPLA3 increases the susceptibility to non‐alcoholic fatty liver disease caused by obesity and metabolic disorders
Mingfeng Xia, Y. Ling, Hua Bian, H.‐D. Lin, Hongmei Yan, X.‐X. Chang, X.‐M. Li, Hui Ma, D. Wang, Lida Zhang et al. · 2016 · Alimentary Pharmacology & Therapeutics
Discovery and Targeting of the Signaling Controls of PNPLA3 to Effectively Reduce Transcription, Expression, and Function in Pre-Clinical NAFLD/NASH Settings
Brian E. Schwartz, Vaishnavi Rajagopal, Cynthia J. Smith, Evan Cohick, Gavin Whissell, Mario E. Gamboa, Rutuja Pai, Alla A. Sigova, Iris Grossman, David A. Bumcrot et al. · 2020 · Cells
Genetic Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease
Yiying Pei, George Boon‐Bee Goh · 2025 · Gut and Liver
PNPLA3 Polymorphisms and Liver Aminotransferase Levels in a Mexican American Population
Quan Li, Hui‐Qi Qu, Anne R. Rentfro, Megan L. Grove, Shaper Mirza, Lu Yang, Craig L. Hanis, Michael B. Fallon, Eric Boerwinkle, Susan P. Fisher‐Hoch et al. · 2012 · Clinical and investigative medicine
Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study
Pavel Trunečka, Irena Míková, Dana Dlouhá, Jaroslav Alois Hubacek, Eva Honsová, Libor Kolesár, Věra Lánská, Soňa Fraňková, Jan Šperl, Milan Jirsa et al. · 2018 · Digestive and Liver Disease
Parental non‐alcoholic fatty liver disease increases risk of non‐alcoholic fatty liver disease in offspring
Michelle T. Long, Ellen B. Gurary, Joseph M. Massaro, Jiantao Ma, Udo Hoffmann, Raymond T. Chung, Emelia J. Benjamin, Rohit Seth Loomba · 2018 · Liver International
A missense variant in Mitochondrial Amidoxime Reducing Component 1 gene and protection against liver disease
Connor A. Emdin, Mary Haas, Amit V. Khera, Krishna G. Aragam, Mark D. Chaffin, Lan Jiang, Wei‐Qi Wei, QiPing Feng, Juha M Karjalainen, Aki Samuli Havulinna et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
The impact of patatin-like phospholipase domain-containing protein 3 polymorphism on hepatocellular carcinoma prognosis
Yasuto Takeuchi, Fusao Ikeda, Yuki Moritou, Hiroaki Hagihara, Tetsuya Yasunaka, Kenji Kuwaki, Yasuhiro Miyake, Hideki Ohnishi, Shinichiro Nakamura, Hidenori Shiraha et al. · 2012 · Journal of Gastroenterology
Patatin-Like Phospholipase Domain-Containing 3 and the Pathogenesis and Progression of Pediatric Nonalcoholic Fatty Liver Disease
Jeffrey D. Browning, Jonathan C. Cohen, Helen H. Hobbs · 2010 · Hepatology
Role of the type 3 cytokines IL-17 and IL-22 in modulating metabolic dysfunction-associated steatotic liver disease
Mohamed N. Abdelnabi, Ghada S. Hassan, Naglaa H. Shoukry · 2024 · Frontiers in Immunology
Non-alcoholic fatty liver disease: what's new under the microscope?
Elizabeth M. Brunt · 2011 · Gut
Pathophysiology of Nonalcoholic Fatty Liver Disease: Lifestyle-Gut-Gene Interaction
Arianna Mazzotti, Maria Turchese Caletti, Anna Simona Sasdelli, Lucia Brodosi, Giulio Marchesini · 2016 · Digestive Diseases
Insights into genetic variants associated with NASH-fibrosis from metabolite profiling
Jake Peter Mann, Maik Pietzner, Laura B. L. Wittemans, Emmanuela De Lucia Rolfe, Nicola D. Kerrison, Fumiaki Imamura, Nita G. Forouhi, Eric B. Fauman, Michael Allison, Jules L Griffin et al. · 2020 · Human Molecular Genetics
Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases
Vincent Zimmer, Frank Lammert · 2011 · Best Practice & Research Clinical Gastroenterology
The PNPLA3 rs738409 G-Allele Associates with Reduced Fasting Serum Triglyceride and Serum Cholesterol in Danes with Impaired Glucose Regulation
Nikolaj Thure Krarup, Niels Grarup, Karina Banasik, Martin Haljeta Friedrichsen, Kristine Færch, Camilla Helene Sandholt, Torben Jørgensen, Pernille Poulsen, Daniel R. Witte, Allan Arthur Vaag et al. · 2012 · PLoS ONE
Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population
Yiling Li, Chao Xing, Zhong Tian, Hung-Chih Ku · 2012 · BMC Medical Genetics
Omic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease
Xuelin Zhang, Yang Wang, Pingsheng Liu · 2016 · Protein & Cell
I148 M variant in PNPLA 3 reduces central adiposity and metabolic disease risks while increasing nonalcoholic fatty liver disease
Jin‐Ho Park, Belong Cho, Hyuktae Kwon, Daria Prilutsky, Jae Moon Yun, Ho-Chun Choi, Kyu‐Baek Hwang, In‐Hee Lee, Jong‐Il Kim, Sek Won Kong · 2015 · Liver International
Heterogeneity of non-alcoholic fatty liver disease (NAFLD): Implication for cardiovascular risk stratification
Francesco Baratta, Laura D’Erasmo, Simone Bini, Daniele Pastori, Francesco Angelico, Maria Del Ben, Marcello Arca, Alessia Di Costanzo · 2022 · Atherosclerosis
Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study
Vishnubhotla Venkata Ravi Kanth · 2014 · World Journal of Hepatology
Hepatocyte-Specific Ptpn6 Deletion Promotes Hepatic Lipid Accretion, but Reduces NAFLD in Diet-Induced Obesity: Potential Role of Pparγ
Elaine Xu, Marie‐Pier Forest, Michael G. Schwab, Rita Kohen Avramoglu, Emmanuelle St-Amand, Annabelle Z. Caron, Kerstin Bellmann, Michaël Shum, Grégory Voisin, Marilène Paquet et al. · 2013 · Hepatology
The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
Rohini Mehta, Kianoush Jeiran, Aaron B. Koenig, Munkzhul Otgonsuren, Zachary D Goodman, Ancha V. Baranova, Zobair M. Younossi · 2016 · BMC Medical Genetics
I148M PNPLA3 variant and progressive liver disease: A new paradigm in hepatology
Luca V. C. Valenti, Anna Alisi, Valério Nobili · 2012 · Hepatology · Retracted
Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis
Julia Kozlitina · 2020 · Gastroenterology Clinics of North America
CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis
Liqing Yu, Yi Li, Alison Grisé, Huan Wang · 2020 · Advances in experimental medicine and biology
Increased parenchymal damage and steatohepatitis in Caucasian non-alcoholic fatty liver disease patients with common IL1B and IL6 polymorphisms
James E. Nelson, P. Handa, Bradley E. Aouizerat, Laura Wilson, Lakshmisree Akhila Vemulakonda, Matthew M. Yeh, Kris V. Kowdley · 2016 · Alimentary Pharmacology & Therapeutics
The PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes
Mingfeng Xia, Huandong Lin, Lingyan Chen, Li Wu, Hui Ma, Qian Li, Qiqige Aleteng, Yu Hu, Wanyuan He, Jian Gao et al. · 2019 · Diabetologia
Genome‐Wide Association Study Identifies Loci for Liver Enzyme Concentrations in Mexican Americans: The GUARDIAN Consortium
Kendra A. Young, Nicholette D. Palmer, Tasha E. Fingerlin, Carl D. Langefeld, Jill M. Norris, Nan Wang, Anny H. Xiang, Xiuqing Guo, Adrienne H. Williams, Yii‐Der Ida Chen et al. · 2019 · Obesity
PNPLA3 rs738409 and risk of fibrosis in NAFLD: Exploring mediation pathways through intermediate histological features
Eduardo Vilar Gómez, Carlos Jose Pirola, Silvia C. Sookoian, Laura Wilson, Tiebing Liang, Naga Chalasani · 2022 · Hepatology
Distinct hepatocyte identities in liver homeostasis and regeneration
Chen, Feng, Schönberger, Katharina, Tchorz, Jan S. · 2023 · JHEP Reports
Non-alcoholic fatty liver disease, metabolic syndrome and patatin-like phospholipase domain-containing protein3 gene variants
Maria Del Ben, Licia Polimeni, Monica Brancorsini, Alessia Di Costanzo, Laura D’Erasmo, Francesco Baratta, Lorenzo Loffredo, Daniele Pastori, Pasquale Pignatelli, Francesco Violi et al. · 2014 · European Journal of Internal Medicine
The association of nonalcoholic fatty liver disease with genetic polymorphisms: a multicenter study
Ahmet Uygun, Kadir Öztürk, Hakan Demirci, Ali Öztuna, Fatih Eren, Salih Kozan, Yusuf Nadir Yilmaz, Ömer Kurt, Türker Türker, Sezgin Vatansever et al. · 2017 · European Journal of Gastroenterology & Hepatology
Body composition and genetic lipodystrophy risk score associate with nonalcoholic fatty liver disease and liver fibrosis
Chen, Vincent L., Wright, Andrew P., Halligan, Brian, Chen, Yanhua, Du, Xiaomeng, Handelman, Samuel K., Long, Michelle T., Kiel, Douglas P., Speliotes, Elizabeth K. · 2019 · Hepatology Communications
Systematic review of genetic association studies involving histologically confirmed non-alcoholic fatty liver disease
Kayleigh L. Wood, Michael H. Miller, John Francis Dillon · 2015 · BMJ Open Gastroenterology
Characterization of essential domains in HSD17B13 for cellular localization and enzymatic activity
Yanling Ma, Suman Karki, Philip M. Brown, Dennis D. Lin, Maren Catherina Podszun, Wenchang Zhou, Olga V. Belyaeva, Natalia Y. Kedishvili, Yaron Rotman · 2020 · Journal of Lipid Research
ABHD5—A Regulator of Lipid Metabolism Essential for Diverse Cellular Functions
Margarita Schratter, Achim Lass, Franz P.W. Radner · 2022 · Metabolites
The Association of Genetic Variants with Hepatic Steatosis in Patients with Genotype 1 Chronic Hepatitis C Infection
Paul J. Clark, Alexander J. Thompson, Qianqian Zhu, David M. Vock, Mingfu Zhu, Keyur Patel, Stephen A. Harrison, Susanna Naggie, Dongliang Ge, Hans Ludger Tillmann et al. · 2012 · Digestive Diseases and Sciences
Patatin‐like phospholipase domain containing 3 variants differentially impact metabolic traits in individuals at high risk for cardiovascular events
Sabrina Rüschenbaum, Katharina Maria Schwarzkopf, Mireen Friedrich‐Rust, Florian Hartmut Seeger, Fabian Schoelzel, Yolanda Martinez, Stefan Zeuzem, Jörg Bojunga, Christian Markus Lange · 2018 · Hepatology Communications
Racial disparities in nonalcoholic fatty liver disease clinical trial enrollment: A systematic review and meta-analysis
Parita Patel, Charles Muller, Sonali Paul · 2020 · World Journal of Hepatology
Gene-Environmental Interactions as Metabolic Drivers of Nonalcoholic Steatohepatitis
Somaya A. M. Albhaisi, Arun Jayant Sanyal · 2021 · Frontiers in Endocrinology
Endocrine disrupting chemicals: A promoter of non-alcoholic fatty liver disease
Yajie Chen, Yang Wang, Ziqiang Cui, Wenpeng Liu, Baowang Liu, Qiang Zeng, Xin Zhao, Jian Dou, Jinglin Cao · 2023 · Frontiers in Public Health
Donor PNPLA3 and TM6SF2 Variant Alleles Confer Additive Risks for Graft Steatosis After Liver Transplantation
Irena Míková, Magdaléna Neřoldová, Jaroslav Alois Hubacek, Dana Dlouhá, Milan Jirsa, Eva Honsová, Eva Sticová, Věra Lánská, Julius Špičák, Pavel Trunečka · 2019 · Transplantation
Sex and Menopause Modify the Effect of Single Nucleotide Polymorphism Genotypes on Fibrosis in NAFLD
Kara Wegermann, Melanie E. Garrett, Jiayin Zheng, Andrea D. Coviello, Cynthia A. Moylan, Manal F. Abdelmalek, Shein‐Chung Chow, Cynthia D. Guy, Anna Mae Diehl, Allison E. Ashley‐Koch et al. · 2021 · Hepatology Communications
Impact of PNPLA3 and TM6SF2 polymorphisms on the prognosis of patients with MASLD and type 2 diabetes mellitus
Natália Lavrado, Gil Fernando Salles, Claudia R.L. Cardoso, Paulo Henrique Condeixa de França, Maria Fernanda Di Guimarães Gonçalves Melo, Nathalie Carvalho Leite, Cristiane Alves Villela‐Nogueira · 2024 · Liver International
Sex and race differences in the prevalence of fatty liver disease as measured by computed tomography liver attenuation in European American and African American participants of the NHLBI family heart study
Kari E. North, Mariaelisa Graff, Nora Franceschini, Alex P. Reiner, Mary Furlan Feitosa, J. Jeffrey Carr, Penny Gordon‐Larsen, Mary K. Wojczynski, Ingrid B. Borecki · 2011 · European Journal of Gastroenterology & Hepatology
PNPLA3, a genetic marker of progressive liver disease, still hiding its metabolic function?
Caroline Dubuquoy, Anne‐Françoise Burnol, Marthe Moldes · 2012 · Clinics and Research in Hepatology and Gastroenterology
Phosphatidylethanolamine N-methyltransferase gene rs7946 polymorphism plays a role in risk of nonalcoholic fatty liver disease
Hwa‐Li Tan, Rosmawati Binti Mohamed, Zahurin Mohamed, Shamsul Mohd Zain · 2015 · Pharmacogenetics and Genomics
ADSA Foundation Scholar Award: Influencing hepatic metabolism: Can nutrient partitioning be modulated to optimize metabolic health in the transition dairy cow?
Heather Muse White · 2020 · Journal of Dairy Science